|
AHCYL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.06269998251452E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.05649999649194E-08 |
| Normal-vs-Stage2 |
1.084010E-02 |
| Normal-vs-Stage3 |
1.95729999985517E-08 |
| Normal-vs-Stage4 |
6.215100E-04 |
| Stage1-vs-Stage2 |
4.246600E-01 |
| Stage1-vs-Stage3 |
1.577560E-01 |
| Stage1-vs-Stage4 |
6.287000E-01 |
| Stage2-vs-Stage3 |
1.770810E-01 |
| Stage2-vs-Stage4 |
3.936000E-01 |
| Stage3-vs-Stage4 |
9.225400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.10778094767284E-12 |
| Normal-vs-AfricanAmerican |
7.840600E-04 |
| Normal-vs-Asian |
1.304400E-02 |
| Caucasian-vs-AfricanAmerican |
1.444210E-01 |
| Caucasian-vs-Asian |
8.585200E-01 |
| AfricanAmerican-vs-Asian |
7.103600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.15172365772787E-12 |
| Normal-vs-Female |
3.638000E-04 |
| Male-vs-Female |
2.490800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.48909999999158E-05 |
| Normal-vs-Extreme_Weight |
8.21730461453285E-11 |
| Normal-vs-Obese |
2.207600E-04 |
| Normal-vs-Extreme_Obese |
2.178500E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.542800E-01 |
| Normal_Weight-vs-Obese |
2.396400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.777600E-01 |
| Extreme_Weight-vs-Obese |
6.380000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.522400E-01 |
| Obese-vs-Extreme_Obese |
6.651800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.29070000021159E-07 |
| Normal-vs-Age(41-60Yrs) |
7.97019999998483E-07 |
| Normal-vs-Age(61-80Yrs) |
2.11339999944826E-08 |
| Normal-vs-Age(81-100Yrs) |
6.30670000000277E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.879500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.177000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.695200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.797030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.474780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.768800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.76060277468082E-11 |
| Normal-VS-Type2 PRCC |
1.432270E-04 |
| Normal-VS-KIRP CIMP |
1.81159998113856E-09 |
| Normal-VS-Unclassified PRCC |
1.177060E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.293400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.895900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.010200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.136900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.012400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.561500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.41559999675434E-09 |
| Normal-vs-N1 |
9.36820000019267E-07 |
| Normal-vs-N2 |
1.68240000042452E-07 |
| N0-vs-N1 |
7.151200E-01 |
| N0-vs-N2 |
4.774600E-01 |
| N1-vs-N2 |
4.943400E-01 |
|
|
